The mechanism of action of Ad5/3-E2F-d24-vIL2 appears more refined than its wt IL-2 armed counterpart, as evidenced by lower levels of necrosis and fewer suppressive myeloid effects at the tumor site. Here, EZR is linked to neoplasm.